The STEP 4 trial demonstrated that participants who discontinued semaglutide after 20 weeks regained approximately two-thirds of lost weight over the next 48 weeks
Potential Spread of PBM Guidelines There is a significant concern that these restrictive PBM guidelines could spread to other PBMs, further limiting access to essential medications for patients across the country
Rybelsus (semaglutide) is the first FDA-approved oral GLP-1 agonist for patients with type 2 diabetes to improve blood sugar levels when combined with exercise and lifestyle changes
Four low cost collaboration models that actually work Below are four practical models coaches use to launch and scale GLP-1 programs in partnership with turnkey telehealth providers
Through a comprehensive plan, she found success and now shes passionate about guiding others on the same path
Our platform offers access to a variety of solutions, from branded medications like Ozempic and Mounjaro to compounded alternatives, all supported by a team that cares about your individual success